Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
911
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
-681K
-
Total reported value, excl. options
-
$24.8B
-
Value change
-
-$153M
-
Put/Call ratio
-
1.13
-
Number of buys
-
356
-
Number of sells
-
-444
-
Price
-
$203.94
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q2 2022
1,071 filings reported holding BIIB - BIOGEN INC. - COM as of Q2 2022.
BIOGEN INC. - COM (BIIB) has 911 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
of 147M outstanding shares and own 83.07% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15.7M shares), BlackRock Inc. (14.5M shares), VANGUARD GROUP INC (11.9M shares), STATE STREET CORP (6.88M shares), WELLINGTON MANAGEMENT GROUP LLP (6.29M shares), GEODE CAPITAL MANAGEMENT, LLC (3.25M shares), JPMORGAN CHASE & CO (1.98M shares), Clearbridge Investments, LLC (1.97M shares), NORTHERN TRUST CORP (1.71M shares), and DEUTSCHE BANK AG\ (1.67M shares).
This table shows the top 911 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.